Miromatrix Medical Inc. engages in the development of biological human organs to solve the chronic shortage of transplantable organs. 114,000 people in the U.S. are waiting for a life-saving organ transplant, and more than half will die due to a lack of available organs. Miromatrix Medical trial is expected to begin in the second half of 2022 and will assess the...
All, ABCL is for massively oversold on weekly down so regardless how you feel about the stock (even though price target analysts are WAY higher) this is due for a rip. Not to mention this is a perfect situation for institutions to enter into ABCL at a pretty big discount from fair value etc. I am temporarily waiting next few days watch it extremely closely then...
All, I think CEMI is due for a huge run here oversold massively on almost all timeframes like daily/weekly. This has been building up and end of pattern now. I'd either scale in or get OTM options but further out.
All, ABCL in a pretty solid spot here imo. Definitely need conformation of bottom here, candle looks to be a reversal possibly. I would look at 17-20$ calls OTM longer term or leveraged stock position hold long with a very tight stop loss. Could drop one more level. Just watch, slap some alerts on it but ABCL definitely imo worth 20-22.
Broke one downtrend one more to go. Soon be sooner than later.
$SRNE has bounced off of the .618 fib level, which could mean a break to the recent high. I am anticipating a touch to the $15 zone within the next couple of months. Good Luck!
lol if this pans out greatest gains ever
Since 1969 BMY has been around yes. The fact this is chartable is wild. I think we see 70+ in 2-3 weeks 80+ after that new all time highs. I already am accumulating 700+ OTM options.
No there is nothign wrong with this stock its a typical bio downtrend. I think this is due for a massssssssive move. I actually rarely pay much attention to indicators regardless how many I have / most the time zoomed in double clicked in just using volume etc. However, to find end of long term downtrends they can be extremely useful on these. Bollinger Bands...
All, I think this has a massive play possible here. Why: -Confleunce support (horizontally) + trend support -Falling wedge downtrend -40MA tight against trend (if you're a VWAP person I'm sure you would see a VWAP play) -RSI/MACD both good Recent news very positive. Looking into options Monday.
All, I think you see some erie similarities and the extreme HL aka bullish moves and could form ascend bullish triangle here. Earnings is June 29th being bio may or may not matter more than likely nuetral. Regardless solid setup here either way if it pops here and holds the ascend tri / a fall I believe would just set up for the exact same thing which wold be a...
Nemaura Medical (NMRD) said early Wednesday it received a purchase order for 200,000 sugarBEAT sensors and 5,000 sugarBEAT transmitters from its UK licensee DB Ethitronix. Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. The company provides sugarBEAT, a non-invasive continuous glucose...
$OCGN next Target PT 70 and higher, long term PT 180 and higher $OCGN " The Ocugen team has submitted a comprehensive drug master file with the FDA, and is currently diligently preparing the EUA application, according to Shankar Musunuri, Chairman of the Board, CEO and and co-founder of Ocugen."
Trend-base Fib Extension... Why Vaxart Stock Is Surging Today Investors are excited about the company's experimental COVID-19 vaccine. What happened Shares of Vaxart (NASDAQ:VXRT) climbed on Tuesday after the biotech released promising data from a clinical trial of its oral coronavirus vaccine candidate. As of 3:30 p.m. EDT, Vaxart's stock price was up more...
Pivoting off Support and up-trending towards Resistance, time sequence within Wave analysis Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to...
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing approaches for the management of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement...
Buy put spreads for April on this name. I think 180/165 put debit 4/19 would do well. XBI is under a lot of pressure, this company has nothing fresh right now, massive head and shoulders. Get it back in that safe channel
As long as the company continues to provide decent news and progress, I believe this pattern will prove itself. The market went down hard at yesterday's session and recovered strongly, I believe that SRNE weak hands were washed out in that move and now it will be easier for it to move towards the highs. If the volume goes down and the price will move...